Production of interferon-γ-inducible protein-10 and its role as an autocrine invasion factor in nasal natural killer/T-cell lymphoma cells

Clinical Cancer Research

Volumn 15, Issue 22, 2009, Pages 6771-6779

  Moriai, Shigetaka ^a   Takahara, Miki ^a   Ogino, Takeshi ^a   Nagato, Toshihiro ^a   Kishibe, Kan ^a   Ishii, Hideyuki ^a   Katayama, Akihiro ^a   Shimizu, Norio ^b   Harabuchi, Yasuaki ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10;

ADULT; AGED; ARTICLE; CANCER CELL; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; MALE; NK T CELL LYMPHOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MICROARRAY; REMISSION; T CELL LYMPHOMA; TUMOR BIOPSY;

ADULT; AGED; BIOPSY; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINE CXCL10; CHEMOKINES; FEMALE; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; REMISSION INDUCTION;

EID: 72549086628     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-1052     Document Type: Article

References (46)

1. Spear GS, Walker WG, Jr. Lethal midline granuloma (granuloma gangraenescens) at autopsy; report of a case and review of literature. Bull Johns Hopkins Hosp 1956;99:313-332
2. Harabuchi Y, Imai S, Wakashima J, et al. Nasal T-cell lymphoma causally associated with Epstein- Barr virus: clinicopathologic, phenotypic, and genotypic studies. Cancer 1996;77:2137-2149 (Pubitemid 26142062)
3. Aozasa K, Ohsawa M, Tajima K, et al. Nationwide study of lethal mid-line granuloma in Japan: frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. Int J Cancer 1989; 44:63-66 (Pubitemid 19184678)
4. Harabuchi Y, Yamanaka N, Kataura A, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990;335:128-130 (Pubitemid 20032725)
5. Kanavaros P, Lescs MC, Briere J, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993;81:2688-2695 (Pubitemid 23147574)
6. Emile JF, Boulland ML, Haioun C, et al. CD5-56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 1996;87:1466-1473
7. Jaffe ES, Chan JK, Su IJ, et al. Report of the workshop on nasaland related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differentialdi agnosis, and epidemiology. Am J Surg Pathol 1996;20:103-111
8. Yamanaka N, Harabuchi Y, Sambe S, et al. Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity. Clinical and immunologic aspects. Cancer 1985;56:768-776
9. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-1392 (Pubitemid 24273002)
10. Eichel BS, Harrison EG, Jr., Devine KD, Scanlon PW, Brown HA. Primary lymphoma of the nose including a relationship to lethal midline granuloma. Am J Surg 1966;112:597-605.
11. Nagata H, Konno A, Kimura N, et al. Characterization of novel natural killer (NK)-cell and γδ T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus. Blood 2001;97:708-713
12. Minarovits J, Hu LF, Imai S, et al. Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas. J Gen Virol 1994;75:77-84. (Pubitemid 24033982)
13. Nagato T, Kobayashi H, Kishibe K, et al. Expression of interleukin-9 in nasal natural killer/ T-cell lymphoma cell lines and patients. Clin Cancer Res 2005;11:8250-8257
14. Takahara M, Kis LL, Nagy N, et al. Concomitant increase of LMP1 and CD25 (IL-2-receptor α) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3. Int J Cancer 2006;119: 2775-2783
15. Wang JM, Deng X, Gong W, Su S. Chemokines and their role in tumor growth and metastasis. J Immunol Methods 1998;220:1-17. (Pubitemid 28527062)
16. Maggio E, van den Berg A, Diepstra A, Kluiver J, Visser L, Poppema S. Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues. Ann Oncol 2002;13 Suppl 1:52-56
17. Laurence AD. Location, movement and survival: the role of chemokines in haematopoiesis and malignancy. Br J Haematol 2006;132:255-267
18. Baumforth KR, Birgersdotter A, Reynolds GM, et al. Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates up-regulation of CCL20 and the migration of regulatory T cells. Am J Pathol 2008;173:195-204.
19. Uchihara JN, Krensky AM, Matsuda T, et al. Transactivation of the CCL5/RANTES gene by Epstein-Barr virus latent membrane protein 1. Int J Cancer 2005;114:747-755 (Pubitemid 40344436)
20. Vockerodt M, Pinkert D, Smola-Hess S, et al. The Epstein-Barr virus oncoprotein latent membrane protein 1 induces expression of the chemokine IP-10: importance of mRNA half-life regulation. Int J Cancer 2005;114:598-605.
21. Ren Q, Sato H, Murono S, Furukawa M, Yoshizaki T. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin- 8 through the nuclear factor-κ B signaling pathway in EBV-infected nasopharyngealca rcinoma cell line. Laryngoscope 2004;114:855-859
22. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting- Airlie House, Virginia, November, 1997. Hematol J 2000;1:53-66.
23. Harabuchi Y, Tsubota H, Ohguro S, et al. Prognostic factors and treatment outcome in non- Hodgkin's lymphoma of Waldeyer's ring. Acta Oncol1997;36:413-420
24. Harabuchi Y, Takahara M, Kishibe K, Moriai S, Nagato T, Ishii H. Nasal natural killer (NK)/T-cell lymphoma: clinical, histological, virological, and genetic features. Int J Clin Oncol 2009;14:181-190
25. Tsuge I, Morishima T, Morita M, Kimura H, Kuzushima K, Matsuoka H. Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line. Clin Exp Immunol 1999;115:385-392
26. Yagita M, Huang CL, Umehara H, et al. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia 2000; 14:922-930 (Pubitemid 30235072)
27. Gong JH, Maki G, Klingemann HG. Characterization of a human cell line (NK-92) with phenotypicaland functional characteristics of activated natural killer cells. Leukemia 1994;8:652-658
28. Epstein MA, Achong BG, Barr YM, Zajac B, Henle G, Henle W. Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J Natl Cancer Inst 1966;37:547-559
29. Nakamura S, Katoh E, Koshikawa T, et al. Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese. PatholInt 1997;47:38-53. (Pubitemid 27085903)
30. Ohshima K, Karube K, Kawano R, et al. Classification of distinct subtypes of peripheral T-cel l lymphoma unspecified, identified by chemokine and chemokine receptor expression: analysis of prognosis. Int J Oncol2004;25:605-613
31. Nakayama T, Fujisawa R, Izawa D, Hieshima K, Takada K, Yoshie O. Human B cells immortalized with Epstein-Barr virus upregulate CCR6 and CCR10 and downregulate CXCR4 and CXCR5. J Virol2002;76:3072-3077
32. Albini A, Iwamoto Y, Kleinman HK, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987;47:3239-3245 (Pubitemid 17082655)
33. Luster AD, Unkeless JC, Ravetch JV. γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 1985;315:672-676
34. Luster AD, Ravetch JV. Biochemicalcharacterization of a γ interferon-inducible cytokine (IP- 10). J Exp Med 1987;166:1084-1097
35. Taub DD, Lloyd AR, Conlon K, et al. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 1993;177:1809-1814 (Pubitemid 23146150)
36. Taub DD, Sayers TJ, Carter CR, Ortaldo JR. α and β chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol 1995;155:3877-3888
37. Teruya-Feldstein J, Jaffe ES, Burd PR, Kingma DW, Setsuda JE, Tosato G. Differentialc hemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia. Blood 1999;93:2463-2470
38. Giuliani N, Bonomini S, Romagnani P, et al. CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival. Haematologica 2006;91:1489-1497 (Pubitemid 44736115)
39. Zipin-Roitman A, Meshel T, Sagi-Assif O, et al. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. Cancer Res 2007;67:3396-3405 (Pubitemid 46724880)
40. Ohshima K, Karube K, Hamasaki M, et al. Differentialchemoki ne, chemokine receptor and cytokine expression in Epstein-Barr virus-associated lymphoproliferative diseases. Leuk Lymphoma 2003;44:1367-1378 (Pubitemid 36764292)
41. Teruya-Feldstein J, Jaffe ES, Burd PR, et al. The role of Mig, the monokine induced by interferon-γ, and IP-10, the interferon-γ- inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. Blood 1997;90:4099-4105
42. Yagi H, Seo N, Ohshima A, et al. Chemokine receptor expression in cutaneous T cell and NK/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay. Am J Surg Pathol2006;30:1111-1119
43. Ishida T, Inagaki H, Utsunomiya A, et al. CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheralT- celll ymphoma, unspecified. Clin Cancer Res 2004;10:5494-5500
44. Yao L, Setsuda J, Sgadari C, Cherney B, Tosato G. Interleukin-18 expression induced by Epstein-Barr virus-infected cells. J Leukoc Biol 2001;69:779-784 (Pubitemid 32466417)
45. Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ. Upregulation of tumor necrosis factor-α gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 1997;100:1969-1979
46. Setsuda J, Teruya-Feldstein J, Harris NL, et al. Interleukin-18, interferon-γ, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease. Am J Pathol 1999;155:257-265 (Pubitemid 29318723)